The Economic Case for Pediatric Rare Disease Research

Families bear a disproportionate burden from rare pediatric diseases. Strategic investment in research offers both humanitarian and economic returns.

Unraveling the Persistent Enigma of Severe Hearing Loss Prognosis

Patients presenting with severe to profound sudden sensorineural hearing loss face a complex and often unpredictable recovery trajectory. Understanding the precise factors driving this variability is paramount for effective patient counseling and targeted intervention strategies.

Health insurance and cardiometabolic risk in India

In preventive health services, a quasi-experimental analysis from India examines how health insurance shifts cardiometabolic risk through financial access to screening and treatment . Effect estimates appear modest and heterogeneous, with several 95% CIs overlapping the null, suggesting coverage alone may not reliably change blood pressure or glycemia without strong primary care access. Clinically, delivery systems and medicine continuity remain pivotal.

Why Some Severe Sudden Sensorineural Hearing Loss Cases Don't Recover

Patients presenting with severe to profound sudden sensorineural hearing loss often face a poor prognosis, but early identification of specific risk factors can significantly guide patient counseling. Understanding these indicators allows clinicians to set realistic expectations and potentially tailor more aggressive treatment strategies from the outset.

Health insurance and cardiometabolic risk: signals from India

In India, quasi-experimental analyses of health insurance expansion and cardiometabolic risk examined blood pressure, glycemia, and adiposity. Coverage improved financial protection but showed limited and heterogeneous shifts in risk-factor levels over short horizons. Findings highlight that financial coverage alone may not deliver risk factor control without primary care access, medication continuity, and adherence supports, guiding future policy and implementation priorities.